Physician profile
Stephanie Quist
NPI 1104394717
$3,764.75
in general payments reported to CMS, 2019-2025
21 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $356 · 2022: $267 · 2023: $309 · 2024: $945 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,889 · Education: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,888.84 |
| Education | $252.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $457.46 | 2021-2025 | |
| Janssen Biotech, INC. | $354.56 | 2021-2025 | Tremfya |
| Incyte Corporation | $332.84 | 2024-2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $322.31 | 2021-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $308.65 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $308.31 | 2021-2025 | |
| Ucb, INC. | $277.66 | 2021-2025 | Bimzelx |
| Pfizer INC. | $222.40 | 2024-2025 | |
| Lilly USA, LLC | $216.61 | 2021-2025 | Ebglyss, Taltz |
| Abbvie INC. | $201.16 | 2021-2025 | |
| Amgen INC. | $166.89 | 2021-2025 | Otezla, Otezla |
| Leo Pharma INC. | $149.88 | 2025 | Adbry, Anzupgo |
| Arcutis Biotherapeutics, INC. | $117.65 | 2024-2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $97.83 | 2022-2025 | Sotyktu |
| Organon LLC | $67.01 | 2024-2025 | Hadlima |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $64.95 | 2022 | |
| Fresenius Kabi USA, LLC | $31.00 | 2024 | Idacio |
| Galderma Laboratories, L.P. | $19.62 | 2024 | Aklief |
| Journey Medical Corporation | $17.83 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.23 | 2024 | Spevigo |
| Lnhc, INC | $14.90 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Quist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.